Effect of Kinetic Control Retraining on Neck Proprioception and Functional Outcome in Patients With Cervical Radiculopathy
Launched by CAIRO UNIVERSITY · Jan 27, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new approach called kinetic control retraining to see how it affects neck awareness and overall function in people with cervical radiculopathy, which is a condition that causes pain and weakness in the neck and arm due to nerve issues. The study aims to help patients improve their neck movement and daily activities.
To participate in this trial, you need to be between 40 and 55 years old, have chronic neck pain on one side that has lasted between 3 months and a year, and have a specific type of neck issue confirmed by an MRI. The study is not currently recruiting participants, but if you qualify, you will likely undergo training designed to improve your neck control and see if it helps with your symptoms. It’s important to note that certain medical conditions or previous surgeries could prevent you from participating, so discussing your individual situation with a healthcare provider is essential.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Forty Four patients suffering from chronic cervical unilateral radiculopathy (symptomatic duration) (3 months to 1year).
- • Their age ranges 40-55 years, from both sexes.
- • Body mass index (BMI) of less than 30 Kg/m2
- • Cervical spondylosis (at the levels of C5-C6/C6-C7 confirmed by cervical MRI)..
- Exclusion Criteria:
- • Cervical myelopathy with evidence of pyramidal, posterior column, and or spinothalamic tract lesions.
- • Patients with decreased range of motion of cervical spine secondary to congenital anomalies, musculature contracture, or bony block.
- • Previous cervical or shoulder surgery or trauma.
- • Cervical instability caused by structural problem (e.g. ligament tear or spondylolithesis.
- • Psychological problems interfering with the patient understanding of the orders, or patients who did not have direction preference.
- • Vertebro-basilar artery insufficiency, diabetic neuropathy.
- • Comorbidities that impact physical activity (e.g., cerebrovascular accidents, severe heart disease). - Double crush syndrome and thoracic outlet syndrome.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Damietta, , Egypt
Patients applied
Trial Officials
Nahed Ahmed Salem, PhD
Study Chair
Professor, Cairo university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported